Half-year report · HY
366A.TEDINET S100X4PD
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.5bn | 2025-04-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥14.1bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.1bn | 2024-04-01 → 2024-09-30 | Standalone | Net sales |
| Operating income | ¥610m | 2025-04-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | ¥500m | 2024-04-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | ¥590m | 2025-04-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥502m | 2024-04-01 → 2024-09-30 | Standalone | Ordinary income |
| Profit before tax | ¥590m | 2025-04-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥502m | 2024-04-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income | ¥404m | 2025-04-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | ¥776m | 2024-04-01 → 2025-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥347m | 2024-04-01 → 2024-09-30 | Standalone | Profit loss |
| Total assets | ¥9.2bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥5.2bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥6.7bn | at 2024-09-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.7bn | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥1.7bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥5.4bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥3.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.0bn | at 2024-09-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.6bn | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥4.6bn | at 2025-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2024-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2024-03-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥469m | 2025-04-01 → 2025-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥141m | 2025-04-01 → 2025-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥269m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥137m | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2025-04-01 → 2025-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥213m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥205m | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥69.23 | 2025-04-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥142.47 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.76 | 2024-04-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥67.78 | 2025-04-01 → 2025-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥42.75 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 59.0% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.2% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 6,227,600 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,448,200 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,448,200 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| Health Management Cloud Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥633m |
| Health Management Cloud Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥633m |
| Health Management Cloud Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥363m |
| Medical Checkup Solution Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥6.8bn |
| Medical Checkup Solution Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥6.8bn |
| Medical Checkup Solution Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥232m |
| Medical Institution Support Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥114m |
| Medical Institution Support Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥114m |
| Medical Institution Support Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥15m |
| Health Management Cloud Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥555m |
| Health Management Cloud Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥555m |
| Health Management Cloud Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥321m |
| Medical Checkup Solution Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.4bn |
| Medical Checkup Solution Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.4bn |
| Medical Checkup Solution Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥138m |
| Medical Institution Support Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥148m |
| Medical Institution Support Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥148m |
| Medical Institution Support Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥41m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 410
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding dividend (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc type1 semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes revenue recognition semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Other information financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |